This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-03-14PC DrugAllergySubstance Call Minutes"

From HL7Wiki
Jump to navigation Jump to search
Line 108: Line 108:
 
## CCDA: Emma, Lisa
 
## CCDA: Emma, Lisa
 
## FHIR: Michelle
 
## FHIR: Michelle
 +
 +
<table border="1" cellpadding="2" cellspacing="0" width="100%">
 +
<tr bgcolor=#f0f0f0>
 +
  <th>element</th>
 +
  <th>text</th>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Drug substances</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common Drug Substances for Allergy and Intolerance Documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td></td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td></td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of a medication substance commonly suspected of causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>RxNorm substances of term type ingredient (IN) or multiple ingredient (MIN)</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>Other RxNorm term types</td>
 +
</tr>
 +
</table>
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===

Revision as of 00:26, 15 March 2018

R INFORMATION--> Back to Allergy_&_Intolerance_Drug_Sub-project

Meeting Information

HL7 Negation Requirements Meeting Minutes

Location: Phone

Date: 2018-03-14
Time: 5:00-6:00 ET
Facilitator Jay Lyle Note taker(s) Jay Lyle
Attendee Name Affiliation


y Jay Lyle JP Systems / VA
y Russ Leftwich
y Elaine Ayres
y Stephen Chu
y George Dixon
y Sue Kent
y Lindsey Hoggle
y Yanyan Hu

Agenda

Agenda Topics

  1. VSAC text
  2. Publication of ballot document
  3. Maintenance; liaison with CCDA & FHIR

Minutes

Minutes/Conclusions Reached:

  1. We will continue our meetings at the biweekly Wednesday time until the agenda items are resolved.
  2. Re VSAC stewardship: Jay and Elaine to talk to HL7 HTA about appropriate path. This includes maintenance plans.
  3. VSAC text in process. Note guidance from NLM.
  4. Similar value sets are published by other groups. Check for overlap.
  5. publish in VSAC, using roles (2) and text (3) defined above.
  6. Document publication process steps
    1. Jay finish applying changes, circulate document
    2. After VSAC publication publish, include OIDs
  7. FHIR & CCDA adoption
    1. CCDA: Emma, Lisa
    2. FHIR: Michelle
element text
Drug substances
OID NLM-assigned
Name Common Drug Substances for Allergy and Intolerance Documentation
Author
Steward
Clinical focus Documentation of a medication substance commonly suspected of causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria RxNorm substances of term type ingredient (IN) or multiple ingredient (MIN)
Exclusion criteria Other RxNorm term types

Meeting Outcomes

Actions
  • Please review questions
  • Please review ballot outline


Next Meeting/Preliminary Agenda Items
  • Review draft list
  • Review draft ballot

© 2012 Health Level Seven® International. All rights reserved.

Retrieved from "https://wiki.hl7.org/w/index.php?title=2018-03-14PC_DrugAllergySubstance_Call_Minutes&oldid=154580"